PenderFund Capital Management »

Amicus Therapeutics shares owned by PenderFund Capital Management

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by PenderFund Capital Management from 13F filings

Historical chart of PenderFund Capital Management investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by PenderFund Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by PenderFund Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $594k 41k 14.46
2025-12-31 $170k 12k 14.24

More positions owned by PenderFund Capital Management

First Majestic Silver Corp Note 0.375% 1/1 (Principal)
Northern Oil & Gas Note 3.625% 4/1 (Principal)
Fluence Energy Note 2.250% 6/1 (Principal)
Southern Note 4.500% 6/1 (Principal)
Nio Note 4.625%10/1 (Principal)
Equinox Gold Corp Note 4.750%10/1 (Principal)
Abrdn Platinum Etf Trust Physcl Platm Shs (PPLT)
Duke Energy Corp Note 4.125% 4/1 (Principal)
Nio Note 3.875%10/1 (Principal)
Ppl Cap Fdg Note 2.875% 3/1 (Principal)
Evolent Health Note 3.500%12/0 (Principal)
Wolfspeed Note 2.500% 6/1 (Principal)
Teucrium Commodity Tr Corn Fd Shs (CORN)
Cardlytics Note 4.250% 4/0 (Principal)
Telesat Corp Cl A & Cl B Shs (TSAT)

View all positions for PenderFund Capital Management

Top funds holding Amicus Therapeutics

BlackRock
Vanguard Group
UBS Group
State Street Corporation
Vanguard Capital Management
Pentwater Capital Management
Vanguard Portfolio Management
Glazer Capital
Goldman Sachs Group
Bellevue Group
HBK Investments
Geode Capital Management
Millennium Management
Morgan Stanley
CNH Partners

View all funds holding Amicus Therapeutics